Journal of the American Academy of Child & Adolescent Psychiatry
New researchAsenapine for the Acute Treatment of Pediatric Manic or Mixed Episode of Bipolar I Disorder
Key words
Cited by (0)
The study was designed by Merck and Co., Inc., which had direct oversight or participation in every stage of the study. All authors had full access to the data after study completion and unblinding and are responsible for the work described in this article. All authors were involved in at least 1 of the following: conception, design, acquisition, analysis, and statistical analysis, interpretation of data, and drafting the manuscript and/or revising the manuscript for important intellectual content. All authors provided final approval of the version to be published.
Ms. Braat served as the statistical expert for this research.
Tonya Goodman, BSc, of Arbor Communications, Inc., Ann Arbor, MI provided medical writing services in the preparation of this manuscript, funding for which was provided by Forest Laboratories, LLC, an Allergan affiliate.
Disclosure: Dr. Findling has received research support from, acted as a consultant to, and/or served on a speaker's bureau of Alcobra, Alexza Pharmaceuticals, the American Academy of Child and Adolescent Psychiatry, the American Physician Institute, American Psychiatric Press, Bracket, Bristol-Myers Squibb, CogCubed, Cognition Group, Coronado Biosciences, Dana Foundation, Eli Lilly and Co., Elsevier, Forest, GlaxoSmithKline, Guilford Press, Johns Hopkins University Press, Johnson and Johnson, Jubilant Clinsys, KemPharm, Lundbeck, Merck, the National Institutes of Health, Neurim, Novartis, Otsuka, Oxford University Press, Pfizer, Physicians Postgraduate Press, Purdue, Rhodes Pharmaceuticals, Roche, Sage, Shire, Sunovion, Supernus Pharmaceuticals, Transcept Pharmaceuticals, Validus, and WebMD. Dr. Landbloom is a full-time Merck employee with Merck stock. Dr. Szegedi is a former full-time Merck employee with Merck stock and is a current full-time employee of Actavis, an Allergan affiliate, with Allergan stock. Dr. Zhu is a former full-time employee of Merck and is a current full-time employee of Novartis. Dr. Mackle is a full-time employee of Merck. Dr. Chang has received research support, or has acted as a consultant for Actavis, Eli Lilly and Co., GlaxoSmithKline, Merck, and Sunovion. Dr. Mathews was employed at the time of the study by Forest Research Institute (now Actavis), an Allergan affiliate, and owns stock. Ms. Koppenhaver is a former employee of Merck and holds Merck stock. Ms. Braat is a former full-time employee of Merck.